Breaking News, Collaborations & Alliances

Avalon, GSK Launch Two New Early-Stage Companies

Silarus Therapeutics and Thyritope Biosciences will receive $10M in financing and R&D support

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Avalon Ventures has launched two new companies through its collaboration with GlaxoSmithKline (GSK), Silarus Therapeutics and Thyritope Biosciences. Each will receive as much as $10 million in financing and R&D support from Avalon Ventures and GSK. Both companies will be located at COI Pharmaceuticals in San Diego, an innovation center established by Avalon to provide an R&D facility and operational support to its life science portfolio companies.   The collaboration, established in Apri...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters